RU2487732C2 - Ингалятор, содержащий основание, имеющее, по меньшей мере, одну содержащую лекарственное средство герметичную полость - Google Patents
Ингалятор, содержащий основание, имеющее, по меньшей мере, одну содержащую лекарственное средство герметичную полость Download PDFInfo
- Publication number
- RU2487732C2 RU2487732C2 RU2010133485/14A RU2010133485A RU2487732C2 RU 2487732 C2 RU2487732 C2 RU 2487732C2 RU 2010133485/14 A RU2010133485/14 A RU 2010133485/14A RU 2010133485 A RU2010133485 A RU 2010133485A RU 2487732 C2 RU2487732 C2 RU 2487732C2
- Authority
- RU
- Russia
- Prior art keywords
- cavity
- foil
- base
- attached
- drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 229940079593 drug Drugs 0.000 title claims abstract description 50
- 239000011888 foil Substances 0.000 claims abstract description 171
- 239000012530 fluid Substances 0.000 claims abstract description 32
- 238000000926 separation method Methods 0.000 claims description 91
- 125000006850 spacer group Chemical group 0.000 claims description 47
- 239000011247 coating layer Substances 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 abstract description 8
- 238000007789 sealing Methods 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000002585 base Substances 0.000 description 73
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000003313 weakening effect Effects 0.000 description 7
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 6
- 229960004436 budesonide Drugs 0.000 description 6
- 229960002848 formoterol Drugs 0.000 description 6
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 6
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 6
- 238000003466 welding Methods 0.000 description 6
- 238000004026 adhesive bonding Methods 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229940110309 tiotropium Drugs 0.000 description 5
- 238000009826 distribution Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 description 3
- YEEZWCHGZNKEEK-UHFFFAOYSA-N Zafirlukast Chemical compound COC1=CC(C(=O)NS(=O)(=O)C=2C(=CC=CC=2)C)=CC=C1CC(C1=C2)=CN(C)C1=CC=C2NC(=O)OC1CCCC1 YEEZWCHGZNKEEK-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 229960002714 fluticasone Drugs 0.000 description 3
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 3
- 229960001664 mometasone Drugs 0.000 description 3
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 3
- 229960005127 montelukast Drugs 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229960004764 zafirlukast Drugs 0.000 description 3
- PJFHZKIDENOSJB-UHFFFAOYSA-N Budesonide/formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1.C1CC2=CC(=O)C=CC2(C)C2C1C1CC3OC(CCC)OC3(C(=O)CO)C1(C)CC2O PJFHZKIDENOSJB-UHFFFAOYSA-N 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229940035073 symbicort Drugs 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- RATSWNOMCHFQGJ-TUYNVFRMSA-N (e)-but-2-enedioic acid;n-[2-hydroxy-5-[(1s)-1-hydroxy-2-[[(2s)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide;dihydrate Chemical compound O.O.OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 RATSWNOMCHFQGJ-TUYNVFRMSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- SDASVGARLSZASF-PZGVLSDMSA-N CC1C(C2)[C@H]2C(C(C)C(CC2)=C)[C@H]2C1 Chemical compound CC1C(C2)[C@H]2C(C(C)C(CC2)=C)[C@H]2C1 SDASVGARLSZASF-PZGVLSDMSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 229960000676 flunisolide Drugs 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229940050287 formoterol / mometasone Drugs 0.000 description 1
- 229960003610 formoterol fumarate dihydrate Drugs 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229950004432 rofleponide Drugs 0.000 description 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 description 1
- -1 rrofleponide Chemical compound 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- PJFHZKIDENOSJB-JIVDDGRNSA-N symbicort inhalation aerosol Chemical compound C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O PJFHZKIDENOSJB-JIVDDGRNSA-N 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 229960005105 terbutaline sulfate Drugs 0.000 description 1
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
- A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
- A61M15/0096—Hindering inhalation before activation of the dispenser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/062—Desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Basic Packing Technique (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2786508P | 2008-02-12 | 2008-02-12 | |
| US61/027,865 | 2008-02-12 | ||
| US9025508P | 2008-08-20 | 2008-08-20 | |
| US61/090,255 | 2008-08-20 | ||
| PCT/SE2009/050143 WO2009102275A1 (en) | 2008-02-12 | 2009-02-11 | Inhaler comprising a base having at least one sealed cavity containing medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2010133485A RU2010133485A (ru) | 2012-03-20 |
| RU2487732C2 true RU2487732C2 (ru) | 2013-07-20 |
Family
ID=48986355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010133485/14A RU2487732C2 (ru) | 2008-02-12 | 2009-02-11 | Ингалятор, содержащий основание, имеющее, по меньшей мере, одну содержащую лекарственное средство герметичную полость |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8397718B2 (enExample) |
| EP (1) | EP2252355A4 (enExample) |
| JP (1) | JP2011511690A (enExample) |
| KR (1) | KR20100129726A (enExample) |
| CN (1) | CN101945683B (enExample) |
| AU (1) | AU2009213181B2 (enExample) |
| BR (1) | BRPI0908152A2 (enExample) |
| CA (1) | CA2712603A1 (enExample) |
| MX (1) | MX2010007882A (enExample) |
| NZ (1) | NZ586699A (enExample) |
| RU (1) | RU2487732C2 (enExample) |
| WO (1) | WO2009102275A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
| MX2010007881A (es) * | 2008-02-12 | 2010-08-06 | Astrazeneca Ab | Inhalador que comprende una base que tiene una pluralidad de cavidades selladas que contienen medicamento. |
| WO2010042033A1 (en) * | 2008-10-08 | 2010-04-15 | Astrazeneca Ab | Inhalation device and method of dispensing medicament |
| CA2739068A1 (en) | 2008-10-08 | 2010-04-15 | Astrazeneca Ab | A breath activated inhaler |
| MX2012008508A (es) * | 2010-01-20 | 2012-08-17 | Pfizer Ltd | Dispositivo para suministrar una pluralidad de dosis unitarias de polvo seco, e inhalador que comprende tal dispositivo. |
| WO2013176635A1 (en) * | 2012-05-25 | 2013-11-28 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhaler device having an improved guide gear |
| US9248247B2 (en) * | 2012-07-26 | 2016-02-02 | Nathaniel Gerald Portney | Capsular medication delivery and inhalation device |
| SE539111C2 (en) * | 2015-06-03 | 2017-04-11 | Iconovo Ab | Single dose dry powder inhaler |
| GB201713899D0 (en) * | 2017-08-30 | 2017-10-11 | Indosys Ltd | Multi-dose medicament delivery device |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000053248A1 (en) * | 1999-03-10 | 2000-09-14 | Glaxo Group Limited | Improvements relating to an inhalation device |
| RU2181603C2 (ru) * | 1996-04-25 | 2002-04-27 | Астразенека Аб | Ингалятор |
| WO2005030305A1 (en) * | 2003-09-26 | 2005-04-07 | Innovata Biomed Limited | Assembly for opening medicament containers, particularly containers for a powdered medicament |
| WO2007118343A1 (de) * | 2006-04-13 | 2007-10-25 | Boehringer Ingelheim International Gmbh | Medikamenten-ausgabevorrichtung, medikamentenmagazin dafür und verfahren zur entnahme eines medikaments aus einer medikamentenkammer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
| GB9920839D0 (en) * | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| AU2001250901A1 (en) | 2000-03-27 | 2001-10-08 | Dura Pharmaceuticals, Inc. | Containers for individual doses of an inhalable pharmaceutical |
| US6948494B1 (en) * | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
| US6871647B2 (en) * | 2001-09-19 | 2005-03-29 | Advent Pharmaceuticals Pty Ltd | Inhaler |
| WO2003103563A2 (en) * | 2002-06-07 | 2003-12-18 | Sun Pharmaceutical Industries Limited | Powder inhaler |
| GB2401548B (en) | 2003-05-13 | 2005-07-13 | Boots Healthcare Int Ltd | Improvements relating to vaporisers |
| US20050263153A1 (en) * | 2004-05-28 | 2005-12-01 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
| SE0401654D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | A support structure for a medicament |
| MX2007013272A (es) * | 2005-05-02 | 2008-01-22 | Astrazeneca Ab | Arreglo y metodo para abrir una cavidad, empaque medico y dispositivo de suministro. |
| DE102006023662A1 (de) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalator |
-
2009
- 2009-02-11 AU AU2009213181A patent/AU2009213181B2/en not_active Ceased
- 2009-02-11 US US12/867,466 patent/US8397718B2/en not_active Expired - Fee Related
- 2009-02-11 MX MX2010007882A patent/MX2010007882A/es active IP Right Grant
- 2009-02-11 EP EP09710446.7A patent/EP2252355A4/en not_active Withdrawn
- 2009-02-11 RU RU2010133485/14A patent/RU2487732C2/ru not_active IP Right Cessation
- 2009-02-11 CN CN2009801049722A patent/CN101945683B/zh not_active Expired - Fee Related
- 2009-02-11 BR BRPI0908152-6A patent/BRPI0908152A2/pt not_active IP Right Cessation
- 2009-02-11 NZ NZ586699A patent/NZ586699A/en unknown
- 2009-02-11 CA CA2712603A patent/CA2712603A1/en not_active Abandoned
- 2009-02-11 WO PCT/SE2009/050143 patent/WO2009102275A1/en not_active Ceased
- 2009-02-11 KR KR1020107017835A patent/KR20100129726A/ko not_active Abandoned
- 2009-02-11 JP JP2010546727A patent/JP2011511690A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181603C2 (ru) * | 1996-04-25 | 2002-04-27 | Астразенека Аб | Ингалятор |
| WO2000053248A1 (en) * | 1999-03-10 | 2000-09-14 | Glaxo Group Limited | Improvements relating to an inhalation device |
| WO2005030305A1 (en) * | 2003-09-26 | 2005-04-07 | Innovata Biomed Limited | Assembly for opening medicament containers, particularly containers for a powdered medicament |
| WO2007118343A1 (de) * | 2006-04-13 | 2007-10-25 | Boehringer Ingelheim International Gmbh | Medikamenten-ausgabevorrichtung, medikamentenmagazin dafür und verfahren zur entnahme eines medikaments aus einer medikamentenkammer |
Also Published As
| Publication number | Publication date |
|---|---|
| US20100307491A1 (en) | 2010-12-09 |
| WO2009102275A1 (en) | 2009-08-20 |
| JP2011511690A (ja) | 2011-04-14 |
| CN101945683A (zh) | 2011-01-12 |
| CN101945683B (zh) | 2013-04-17 |
| MX2010007882A (es) | 2010-08-06 |
| AU2009213181B2 (en) | 2012-02-23 |
| RU2010133485A (ru) | 2012-03-20 |
| KR20100129726A (ko) | 2010-12-09 |
| EP2252355A1 (en) | 2010-11-24 |
| US8397718B2 (en) | 2013-03-19 |
| NZ586699A (en) | 2012-04-27 |
| AU2009213181A1 (en) | 2009-08-20 |
| CA2712603A1 (en) | 2009-08-20 |
| EP2252355A4 (en) | 2013-10-02 |
| BRPI0908152A2 (pt) | 2015-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2492877C2 (ru) | Ингалятор, содержащий основание, имеющее большое количество содержащих лекарственное средство герметичных полостей | |
| AU2009213181B2 (en) | Inhaler comprising a base having at least one sealed cavity containing medicament | |
| WO2010021589A1 (en) | Inhaler | |
| RU2514318C2 (ru) | Ингалятор со звуковыми индикаторными средствами | |
| EP2957312B1 (en) | Inhalation device | |
| KR20110074766A (ko) | 흡입 장치 및 의약 분배 방법 | |
| RU2519384C2 (ru) | Активируемый дыханием ингалятор | |
| WO2009102273A1 (en) | Inhaler comprising a plurality of consecutive sealed cavities containing medicaments | |
| JP5918302B2 (ja) | 薬剤を収容する少なくとも１個の封止キャビティを有する基部を備える吸入器 | |
| WO2009102274A1 (en) | Inhaler comprising a base having at least one sealed cavity containing medicament | |
| WO2010024759A1 (en) | Medical dispenser and method of producing a medical dispenser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160212 |